Emma Walmsley on Leading and Leaving GSK | The CEO Signal

Why It Matters

Walmsley’s reforms demonstrate how disciplined curiosity and clear accountability can revitalize a legacy pharma giant, while her proactive succession strategy sets a benchmark for leadership continuity in highly regulated sectors.

Key Takeaways

• Emphasized curiosity and confronting ideas in boardroom discussions.
• Shifted GSK to R&D‑focused model, doubling internal spend.
• Instituted red‑team and pre‑mortem processes for rigorous deal evaluation.
• Prioritized clear accountability, delegating decisions to senior leaders.
• Planned succession from day one, ensuring smooth leadership transition.

Summary

Emma Walmsley, departing CEO of GlaxoSmithKline, sat down for a candid CEO Signal interview to reflect on the full arc of her nine‑year tenure. She described taking the helm in 2017 with a mandate to overhaul a sprawling, underperforming organization, and detailed how personal experiences—from a childhood in a military family to a health crisis involving her children—shaped her urgency and curiosity as a leader.

Walmsley highlighted three strategic pivots: dismantling the legacy consumer‑health business, reinvesting heavily in internal research and development, and embracing external pipelines to fill the drug pipeline. To guard against “deal fever,” she introduced formal red‑team and pre‑mortem analyses, encouraging dissenting views and rigorous scenario planning. She also restructured decision‑making by assigning single‑point accountability, publicly inviting senior leaders to disagree and own outcomes, thereby fostering a performance‑driven culture.

Memorable moments included a candid interview with her successor Luke Miles in a Cambridge wine bar and a public challenge to a head of R&D on a potential acquisition, illustrating her belief that succession planning begins on day one. Walmsley repeatedly stressed the importance of asking tough questions, applauding those who present counter‑arguments, and treating leadership debates as opportunities for learning rather than hierarchy.

The conversation underscores that cultural transformation, disciplined capital allocation, and early succession planning are critical levers for large, regulated firms. Walmsley’s exit signals a new chapter for GSK, but her emphasis on curiosity, accountability, and structured dissent offers a blueprint for CEOs navigating complex, high‑stakes industries.

Original Description

What does it take to hand over a company after years at the helm? Dame Emma Walmsley reflects on her tenure as CEO of GSK at the moment she was preparing to hand over to her successor, Luke Miels. It’s a rare chance to hear a CEO reflect on the full arc of their tenure, from stepping into the role to shaping their own succession.

After nearly a decade leading one of the world’s largest pharmaceutical companies, Walmsley speaks candidly about the realities of the job, from navigating activist pressure to reshaping the company’s strategy and structure.

At the core is responsibility. “No one should take on these jobs without taking on the accountability,” she says.

In moments of pressure, the job is to absorb the noise so the organization can stay focused and perform. During an activist campaign against her leadership, she made a deliberate choice to contain the disruption and keep the company aligned.

Inside GSK, she pushed to shift decision-making toward clearer accountability while encouraging open disagreement at the top. She describes explicitly inviting counterarguments and even staging visible disagreement within her leadership team to normalize challenge.

Looking back, she reflects on how her leadership evolved. Less formal, more focused on communication, and more human.

She is also direct about succession. It is not something that is worked out at the end, she argues, but a responsibility that starts on day one.

About the show

The CEO Signal is Semafor’s interview platform for conversations with the global CEOs whose decisions are shaping the future of the new world economy. Hosted by Penny Pritzker and Andrew Edgecliffe-Johnson, the show explores the moments of judgment that define leadership.

Penny Pritzker is the founder and chairman of PSP Partners and served as U.S. Secretary of Commerce from 2013 to 2017.

Andrew Edgecliffe-Johnson is CEO Editor at Semafor and a veteran Financial Times journalist who has spent decades covering global companies and corporate leadership.

This conversation was recorded in December 2025.